GlassScriptPhysician profile
David A Shenouda
NPI 1326165549
$5,480.89
in general payments reported to CMS, 2019-2025
15 companies · $906 in 2025
The $906 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709 · 2020: $583 · 2021: $341 · 2022: $614 · 2023: $1,271 · 2024: $1,058 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,234.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,900.76 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $469.44 | 2019-2020 | |
| Abbott Laboratories | $411.03 | 2019-2024 | Jot Dx, Cardiomems |
| Biotronik INC. | $318.50 | 2019-2024 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $275.44 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.39 | 2019-2020 | |
| Braemar Manufacturing, LLC | $169.01 | 2019 | |
| Heartflow, INC. | $157.20 | 2025 | |
| Novo Nordisk INC | $137.74 | 2024 | Wegovy |
| Philips North America LLC | $114.93 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Amgen INC. | $89.57 | 2019 | |
| Kestra Medical Technology Services, INC. | $89.05 | 2023 | Assure Wcd |
| Esperion Therapeutics, INC. | $60.04 | 2024-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $30.90 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shenouda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.